[12] Blundell J, et al
The semaglutide weight loss program could be ideal if you have a BMI of 30 or more, or if you are overweight with at least one other weight-related condition
The alteration of the BBB is often marked by a degradation or shrinkage of ECs, alteration of the tight junction proteins connecting cells and modified transport mechanisms which all together impact greatly the BBB permeability
The STEP-5 trial, published in Nature Medicine, evaluated the long-term efficacy of semaglutide 2.4 mg versus placebo in maintaining weight loss over a 2-year period in 304 participants (5)
However, both medications affect the digestive system, and Pepto-Bismol has important UK-specific cautions, including avoidance in children under 16, pregnancy, and breastfeeding
The fact that tirzepatide is on the FDAs shortage list but still marked as available means that 503B pharmacies could also face significant legal risks if they attempt to compound the drug